These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Troglitazone glucuronidation in human liver and intestine microsomes: high catalytic activity of UGT1A8 and UGT1A10. Watanabe Y, Nakajima M, Yokoi T. Drug Metab Dispos; 2002 Dec; 30(12):1462-9. PubMed ID: 12433820 [Abstract] [Full Text] [Related]
3. Identification of UDP-glucuronosyltransferases responsible for the glucuronidation of darexaban, an oral factor Xa inhibitor, in human liver and intestine. Shiraga T, Yajima K, Suzuki K, Suzuki K, Hashimoto T, Iwatsubo T, Miyashita A, Usui T. Drug Metab Dispos; 2012 Feb; 40(2):276-82. PubMed ID: 22031623 [Abstract] [Full Text] [Related]
4. Glucuronidation of edaravone by human liver and kidney microsomes: biphasic kinetics and identification of UGT1A9 as the major UDP-glucuronosyltransferase isoform. Ma L, Sun J, Peng Y, Zhang R, Shao F, Hu X, Zhu J, Wang X, Cheng X, Zhu Y, Wan P, Feng D, Wu H, Wang G. Drug Metab Dispos; 2012 Apr; 40(4):734-41. PubMed ID: 22238289 [Abstract] [Full Text] [Related]
5. In vitro glucuronidation of thyroxine and triiodothyronine by liver microsomes and recombinant human UDP-glucuronosyltransferases. Tong Z, Li H, Goljer I, McConnell O, Chandrasekaran A. Drug Metab Dispos; 2007 Dec; 35(12):2203-10. PubMed ID: 17875670 [Abstract] [Full Text] [Related]
6. Glucuronidation of etoposide in human liver microsomes is specifically catalyzed by UDP-glucuronosyltransferase 1A1. Watanabe Y, Nakajima M, Ohashi N, Kume T, Yokoi T. Drug Metab Dispos; 2003 May; 31(5):589-95. PubMed ID: 12695347 [Abstract] [Full Text] [Related]
7. UGT1A1*28 genotype affects the in-vitro glucuronidation of thyroxine in human livers. Yoder Graber AL, Ramírez J, Innocenti F, Ratain MJ. Pharmacogenet Genomics; 2007 Aug; 17(8):619-27. PubMed ID: 17622938 [Abstract] [Full Text] [Related]
8. Glucuronidation of bavachinin by human tissues and expressed UGT enzymes: Identification of UGT1A1 and UGT1A8 as the major contributing enzymes. Lv X, Hou J, Xia YL, Ning J, He GY, Wang P, Ge GB, Xiu ZL, Yang L. Drug Metab Pharmacokinet; 2015 Oct; 30(5):358-65. PubMed ID: 26320626 [Abstract] [Full Text] [Related]
9. Glucuronidation of thyroxine in human liver, jejunum, and kidney microsomes. Yamanaka H, Nakajima M, Katoh M, Yokoi T. Drug Metab Dispos; 2007 Sep; 35(9):1642-8. PubMed ID: 17591679 [Abstract] [Full Text] [Related]
10. Glucuronidation of DRF-6574, hydroxy metabolite of DRF-4367 (a novel COX-2 inhibitor) by pooled human liver, intestinal microsomes and recombinant human UDP-glucuronosyltransferases (UGT): role of UGT1A1, 1A3 and 1A8. Muzeeb S, Basha SJ, Shashikumar D, Mullangi R, Srinivas NR. Eur J Drug Metab Pharmacokinet; 2006 Sep; 31(4):299-309. PubMed ID: 17315542 [Abstract] [Full Text] [Related]
11. Identification of UDP-glucuronosyltransferase isoforms responsible for leonurine glucuronidation in human liver and intestinal microsomes. Tan B, Cai W, Zhang J, Zhou N, Ma G, Yang P, Zhu Q, Zhu Y. Xenobiotica; 2014 Sep; 44(9):775-84. PubMed ID: 24635759 [Abstract] [Full Text] [Related]
12. Metabolism of the c-Fos/activator protein-1 inhibitor T-5224 by multiple human UDP-glucuronosyltransferase isoforms. Uchihashi S, Fukumoto H, Onoda M, Hayakawa H, Ikushiro S, Sakaki T. Drug Metab Dispos; 2011 May; 39(5):803-13. PubMed ID: 21346002 [Abstract] [Full Text] [Related]
13. Assessment of UDP-glucuronosyltransferase catalyzed formation of Picroside II glucuronide in microsomes of different species and recombinant UGTs. Li T, Zheng Y, Fu F, Ji H, Chen X, Zhao Y, Zhao D, Li N, Zhang L. Xenobiotica; 2011 Jul; 41(7):530-7. PubMed ID: 21524190 [Abstract] [Full Text] [Related]
14. UDP-glucuronosyltransferase (UGT) 1A1 mainly contributes to the glucuronidation of trovafloxacin. Fujiwara R, Sumida K, Kutsuno Y, Sakamoto M, Itoh T. Drug Metab Pharmacokinet; 2015 Feb; 30(1):82-8. PubMed ID: 25760534 [Abstract] [Full Text] [Related]
15. Glucuronidation of mono(2-ethylhexyl) phthalate in humans: roles of hepatic and intestinal UDP-glucuronosyltransferases. Hanioka N, Kinashi Y, Tanaka-Kagawa T, Isobe T, Jinno H. Arch Toxicol; 2017 Feb; 91(2):689-698. PubMed ID: 27071666 [Abstract] [Full Text] [Related]
16. Characterization of raloxifene glucuronidation in vitro: contribution of intestinal metabolism to presystemic clearance. Kemp DC, Fan PW, Stevens JC. Drug Metab Dispos; 2002 Jun; 30(6):694-700. PubMed ID: 12019197 [Abstract] [Full Text] [Related]
17. Hepatic UDP-glucuronosyltransferases responsible for glucuronidation of thyroxine in humans. Kato Y, Ikushiro S, Emi Y, Tamaki S, Suzuki H, Sakaki T, Yamada S, Degawa M. Drug Metab Dispos; 2008 Jan; 36(1):51-5. PubMed ID: 17908920 [Abstract] [Full Text] [Related]
18. Involvement of multiple UDP-glucuronosyltransferase 1A isoforms in glucuronidation of 5-(4'-hydroxyphenyl)-5-phenylhydantoin in human liver microsomes. Nakajima M, Sakata N, Ohashi N, Kume T, Yokoi T. Drug Metab Dispos; 2002 Nov; 30(11):1250-6. PubMed ID: 12386132 [Abstract] [Full Text] [Related]
19. Human liver UDP-glucuronosyltransferase isoforms involved in the glucuronidation of 7-ethyl-10-hydroxycamptothecin. Hanioka N, Ozawa S, Jinno H, Ando M, Saito Y, Sawada J. Xenobiotica; 2001 Oct; 31(10):687-99. PubMed ID: 11695848 [Abstract] [Full Text] [Related]
20. Identification and characterization of human UDP-glucuronosyltransferases responsible for the in-vitro glucuronidation of arctigenin. Xin H, Xia YL, Hou J, Wang P, He W, Yang L, Ge GB, Xu W. J Pharm Pharmacol; 2015 Dec; 67(12):1673-81. PubMed ID: 26407805 [Abstract] [Full Text] [Related] Page: [Next] [New Search]